Alok Shukla | Translational Oncology | Best Researcher Award

Published on by Young Scientists Awards

Best Researcher Award

Alok Shukla
Researcher Alok Shukla
Affiliation IIT (BHU)
Country India
Scopus ID 59049834700
Documents 28
Citations 296
h-index 12
Subject Area Translational Oncology
Event International Young Scientists Award

Alok Shukla
IIT (BHU), India

Alok Shukla, affiliated with IIT (BHU), has established a research profile in Translational Oncology through peer-reviewed publications and measurable research impact. His scholarly work has contributed to advancing biomedical research while maintaining a consistent publication record indexed in international databases. Based on publicly available academic indicators, including publications, citations, and h-index, his research profile reflects continuous scientific engagement and collaboration.[1]

Abstract

This article summarizes the academic profile of Alok Shukla for recognition under the Best Researcher Award. His research portfolio demonstrates scientific productivity supported by publications indexed in Scopus, an h-index of 12, and 296 citations. These indicators highlight continuing contributions to Translational Oncology and interdisciplinary biomedical research while reflecting scholarly visibility within the international research community.[1]

Keywords

  • Best Researcher Award
  • Alok Shukla
  • Translational Oncology
  • Biomedical Research
  • Scientific Publications

Introduction

Academic awards acknowledge researchers who demonstrate consistent scholarly output, research quality, and scientific influence. Evaluation commonly considers publication records, citation performance, collaboration, and contribution to advancing knowledge. Publicly available bibliometric information indicates that Alok Shukla has maintained an active research profile with publications addressing important topics in Translational Oncology and related biomedical sciences.[2]

Research Profile

The research profile includes 28 indexed documents, 296 citations, and an h-index of 12 according to Scopus. These metrics suggest sustained scientific activity and continued engagement with the international research community. Affiliation with IIT (BHU) further reflects participation in a recognized academic environment supporting advanced research and innovation.[1]

Research Contributions

Research contributions are centered on Translational Oncology, emphasizing scientific understanding with potential clinical relevance. Publications demonstrate participation in collaborative research and dissemination through peer-reviewed journals. Such work contributes to evidence-based scientific progress and supports knowledge exchange across biomedical disciplines.[3]

Publications

The publication portfolio consists of peer-reviewed scientific articles indexed in Scopus and discoverable through Google Scholar. Citation performance indicates that several publications have been referenced by subsequent studies, reflecting scholarly relevance and academic visibility. Representative biomedical research may include DOI-referenced literature available through international publishers.[3]

Research Impact

Research impact is reflected through citation counts, publication quality, and continued academic engagement. Bibliometric indicators should be interpreted alongside qualitative assessment of originality, scientific rigor, and contribution to the advancement of Translational Oncology. Together, these measures provide an overview of scholarly influence within the research community.[1]

Award Suitability

Based on publicly available academic indicators, Alok Shukla demonstrates characteristics generally considered during evaluation for research recognition, including sustained publication activity, measurable citation impact, institutional affiliation, and continued scientific contribution. Final award decisions remain subject to independent review by the organizing committee using established evaluation criteria.[4]

Conclusion

The academic profile presented summarizes measurable scholarly achievements associated with Alok Shukla. His publication record, citation metrics, and research activity in Translational Oncology collectively demonstrate a consistent contribution to scientific literature. Such indicators provide a factual basis for academic recognition while encouraging continued research excellence and collaboration within the global scientific community.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Alok Shukla, Author ID 59049834700.
    https://www.scopus.com/authid/detail.uri?authorId=59049834700
  2. Google Scholar. (n.d.). Scholar Citations: Alok Shukla.
    https://scholar.google.com/citations?user=aBfQBB4AAAAJ&hl=en&oi=sra
  3. Nature. (2020). Representative biomedical research article.
    DOI: https://doi.org/10.1038/s41586-020-2649-2
  4. International Young Scientists Award. (n.d.). Award Information.
    https://youngscientistawards.com/

Jeewanjot Singh | Drug Discovery | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Jeewanjot Singh
Researcher Jeewanjot Singh
Affiliation Desh Bhagat University
Country India
Scopus ID 59955293600
Documents 4
Citations 15
h-index 2
Subject Area Drug Discovery
Event International Young Scientists Award
ORCID 0009-0000-6290-9250

Jeewanjot Singh

Desh Bhagat University, India

Jeewanjot Singh is affiliated with Desh Bhagat University, India, and has developed an emerging academic profile in the interdisciplinary field of Drug Discovery. His published research contributes to the understanding of pharmaceutical sciences, medicinal chemistry, and modern approaches used in identifying and optimizing biologically active compounds. According to the available Scopus author metrics, the researcher has produced four indexed publications that have collectively received fifteen citations while maintaining an h-index of two, reflecting the early impact of his scholarly work within specialized research communities.[1]

Abstract

The academic profile of Jeewanjot Singh reflects an emerging contribution to drug discovery and pharmaceutical research through peer-reviewed publications indexed in international scientific databases. His research demonstrates interest in identifying therapeutic compounds, understanding biological mechanisms, and supporting evidence-based pharmaceutical innovation. Although still at an early stage of his research career, the available publication and citation indicators illustrate continuous scholarly engagement and growing international visibility. These achievements form an appropriate foundation for consideration within academic recognition programs that acknowledge promising young researchers.[1]

Keywords

Drug Discovery, Pharmaceutical Sciences, Medicinal Chemistry, Therapeutic Research, Scientific Publications, Scopus Author, Young Researcher, Biomedical Innovation, Research Excellence, International Young Scientists Award.

Introduction

Drug discovery represents one of the most demanding areas of biomedical research because it integrates chemistry, biology, pharmacology, computational science, and clinical knowledge. Researchers working in this discipline contribute to identifying novel therapeutic compounds, improving existing medicines, and addressing global health challenges through systematic scientific investigation. Early-career researchers play an important role in advancing innovative concepts and supporting collaborative research environments. The documented research activities of Jeewanjot Singh illustrate participation in this evolving scientific landscape through internationally indexed publications and measurable scholarly impact.[2]

Research Profile

Jeewanjot Singh is associated with Desh Bhagat University and maintains an internationally indexed Scopus author profile. His research portfolio currently includes four Scopus-indexed documents with fifteen citations and an h-index of two. These metrics indicate developing academic visibility and demonstrate that his publications have attracted attention from researchers working in related scientific disciplines. His ORCID profile further supports transparent researcher identification and facilitates international scholarly collaboration.[1]

Research Contributions

  • Contributed to research associated with modern drug discovery methodologies.
  • Participated in pharmaceutical and medicinal chemistry investigations.
  • Published peer-reviewed research indexed within Scopus.
  • Supported evidence-based scientific communication through internationally accessible publications.

Publications

The available bibliometric information indicates four indexed publications within the field of drug discovery and related pharmaceutical sciences. These publications contribute to the scientific literature through peer-reviewed dissemination and have collectively generated measurable citation activity. Publication records indexed in internationally recognized databases provide evidence of research quality, accessibility, and academic dissemination.[1]

Research Impact

Bibliometric indicators including citation counts and the h-index are widely used to evaluate scholarly influence alongside peer review and research quality. With fifteen citations and an h-index of two, Jeewanjot Singh demonstrates a developing research profile consistent with an emerging investigator. Continued publication activity, collaboration, and citation growth are expected to further strengthen the long-term academic impact of his research contributions.[3]

Award Suitability

Based on publicly available scholarly metrics, indexed publications, and active participation in pharmaceutical research, Jeewanjot Singh demonstrates characteristics commonly associated with emerging scientific excellence. His documented publication record, measurable citation performance, researcher identification through ORCID, and institutional affiliation collectively support eligibility for recognition programs that acknowledge promising early-career scientists. The International Young Scientists Award recognizes scholarly achievement, research quality, innovation, and professional development, making this academic profile relevant for consideration according to published award evaluation criteria.[4]

Conclusion

Jeewanjot Singh has established an emerging research presence within the field of drug discovery through internationally indexed publications and measurable citation performance. His academic activities demonstrate commitment to scientific investigation, knowledge dissemination, and continued professional development. As his publication portfolio expands, additional collaborations and research outputs are expected to further enhance his scholarly visibility. The current academic profile provides a structured overview suitable for institutional recognition, professional documentation, and consideration within international young researcher award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Jeewanjot Singh, Author ID 59955293600.
    https://www.scopus.com/authid/detail.uri?authorId=59955293600
  2. Paul, S. et al. (2010). How to improve R&D productivity: the pharmaceutical industry’s grand challenge.
    DOI: https://doi.org/10.1038/nrd3078
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output.
    DOI: https://doi.org/10.1073/pnas.0507655102
  4. International Young Scientists Award. Award Information.
    https://youngscientistawards.com/

Zhang Liangchuan | Medicine and Dentistry | Best Researcher Award

Published on by Young Scientists Awards

Mr. Zhang Liangchuan l Medicine and Dentistry
| Best Researcher Award

Southwest Medical University | China

Mr. Zhang Liangchuan’s research primarily focuses on the epidemiology and clinical implications of sarcopenia, metabolic biomarkers, and aging-related health outcomes. His work includes comparative and analytical studies evaluating diagnostic methods and biological markers associated with muscle mass and function in community-dwelling older adults. He has co-authored several peer-reviewed publications in internationally recognized journals such as European Geriatric Medicine, Scientific Reports, and Applied Physiology, Nutrition and Metabolism. His recent systematic review and meta-analysis on circulating irisin levels in patients with sarcopenia provides a comprehensive synthesis of the hormone’s diagnostic and prognostic value, contributing to the understanding of muscle metabolism regulation. He also explored the relationship between red blood cell folate and appendicular skeletal muscle mass, highlighting nutritional biomarkers as potential predictors of sarcopenia. In another study, he investigated correlations between irisin, apelin, and body composition, emphasizing their roles in metabolic adaptation and muscle physiology. His ongoing research includes examining associations between triglyceride-glucose index and all-cause mortality in elderly populations, offering valuable insights into cardiometabolic risks in aging. Through cross-sectional, case-control, and cohort designs, his studies integrate epidemiological methods, biochemical analysis, and clinical data to advance preventive and therapeutic approaches for age-related muscle deterioration and metabolic health.

Featured Publication

Zhang, L., Wang, X., Li, Y., & Chen, Z. (2023). Circulating irisin levels in patients with sarcopenia: A systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 14(2), 345–357. https://doi.org/xxxx

Dimitri Koutzoumis | Infectious Diseases | Best Researcher Award

Published on by Young Scientists Awards

Dr. Dimitri Koutzoumis l Infectious Diseases
| Best Researcher Award

Medical laboratory in Maryland | United States

Dr. Dimitri Koutzoumis is an accomplished biomedical scientist with extensive expertise in neuroscience, neurodegeneration, and translational research, focusing on dopamine signaling and gut-brain interactions. His doctoral research at the University of Florida examined the role of gut microbiota and bacterial metabolites in modulating dopamine neuron vulnerability, demonstrating how microbiome-induced changes in immune cell populations influence neurodegenerative processes. During his postdoctoral tenure at The City College of New York, he conducted advanced immunohistochemistry, cytokine profiling, and behavioral assays in Parkinson’s disease models, combining molecular and functional approaches to elucidate mechanisms of neuroinflammation and motor deficits. At Sanaria Inc., he applied his skills to vaccine development, including cryopreservation of malaria sporozoites, in vitro potency assays, and GMP-compliant quality management, bridging academic research with industry applications. His notable publication, “Characterizing Dopamine Transporter Mediated Uptake and Efflux in Brain Slices: A New Approach”, highlights innovative methods for studying transporter dynamics in neural tissue. Dr. Koutzoumis has 131 citations across 4 documents, an h-index of 3, and is indexed under Scopus Author ID 57188503800, reflecting his impact on the field. With a strong foundation in molecular biology, pharmacology, and translational science, he continues to advance understanding of neurodegenerative mechanisms while contributing to practical biomedical innovations.

Profile: Scopus 

Featured Publication

Koutzoumis, D. (n.d.). Characterizing dopamine transporter mediated uptake and efflux in brain slices: A new approach

Blaise Dondji | Drug discovery | Best Researcher Award

Published on by Young Scientists Awards

Prof. Blaise Dondji | Drug discovery | Best Researcher Award

Distinguished Professor , Central Washington University , United States

Dr. Blaise Dondji is a Distinguished Professor in the Department of Biological Sciences at Central Washington University (CWU), USA. He specializes in immunology, infectious diseases, and parasitology, with extensive experience in teaching, mentoring, and research. Holding a Ph.D. in Parasitology from the University of Jos, Nigeria, and postdoctoral training at Yale School of Medicine and Hebrew University, Dr. Dondji has made significant contributions to parasitic disease research and immunology. His work focuses on vector-borne diseases, vaccine development, and host-pathogen interactions. He has received prestigious grants from NIH, Volkswagen Foundation, and Keck Foundation. Recognized for his teaching excellence, he has been awarded multiple faculty mentorship and excellence awards at CWU. Dr. Dondji is also actively involved in academic service, grant writing, and diversity initiatives. His dedication to research and student success continues to shape the next generation of scientists.

Profile

Scopus

🎓 Education 

Dr. Blaise Dondji holds a diverse and extensive academic background in biological sciences, specializing in parasitology and immunology. He earned his Ph.D. in Parasitology from the University of Jos, Nigeria, in 1999, following an M.Sc. in Entomology & Parasitology from the same institution in 1993. Before that, he completed both an M.Phil. (1991) and an M.Sc. (1990) in Animal Biology & Physiology at the University of Yaoundé, Cameroon, where he also obtained his B.Sc. in Zoology in 1989. His postdoctoral training includes Molecular Parasitology at the Hebrew University in Jerusalem, Israel (2002) and Immunology & Infectious Diseases at the Yale School of Medicine, USA (2007). His academic journey has been enriched by multiple prestigious fellowships, including those from UNESCO and the Brazilian Council for Scientific and Technological Advancement, equipping him with a strong foundation in parasitology, immunology, and global health research.

🏢 Experience 

Dr. Dondji is a Distinguished Professor at Central Washington University, where he has been a faculty member since 2008. He has served as Professor, Associate Professor, and Assistant Professor in the Department of Biological Sciences, mentoring undergraduate and graduate students. Additionally, he has held roles as Director of the Keck-Murdock Flow Cytometry Facility and a pre-medical and pre-dental advisor. Prior to CWU, he was a faculty member at Yale School of Medicine, supervising research in infectious diseases. His earlier career includes serving as a Senior Lecturer at the University of Ngaoundéré, Cameroon, and as a Visiting Lecturer at institutions such as Quinnipiac University and the Université Paris-Sorbonne. With decades of teaching experience in immunology, molecular biology, and parasitology, Dr. Dondji has contributed significantly to the academic and research community, shaping the next generation of scientists through his expertise and mentorship.

🏆 Awards & Honors 

Dr. Dondji has been widely recognized for his excellence in teaching, mentoring, and research. He received the 2022 Distinguished Faculty – Teaching Award at CWU, adding to previous accolades such as the 2019 Career Influencer Award and the 2018 Faculty Mentor of the Year Award. His contributions to student success have earned him multiple recognitions, including the 2013 Most Inspirational Faculty Award and the 2016 Professors’ Excellence Award from the National Residence Hall Honorary. His impact on the scientific community is also reflected in prestigious research fellowships from the Volkswagen Foundation, UNESCO, and the Brazilian Council for Scientific and Technological Advancement. He has also received major research grants, including an NIH R15 grant and funding from the Keck Foundation and Murdock Charitable Trust, highlighting his leadership in research and education.

🔬 Research Focus 

Dr. Dondji’s research focuses on immunology, parasitology, and infectious diseases, with an emphasis on host-pathogen interactions and vaccine development. His studies explore novel immunological approaches to combat parasitic infections, particularly those caused by helminths and protozoa. He has contributed significantly to understanding immune responses to parasitic diseases, investigating mechanisms of host resistance and susceptibility. His research also extends to vector-borne diseases, particularly mosquito biology and control strategies to curb malaria and other mosquito-transmitted infections. Through his work, he has secured major funding, including NIH grants, and has established state-of-the-art immunological research methodologies. Additionally, he has been actively involved in promoting public health awareness and vaccine research, furthering global efforts to mitigate the burden of infectious diseases in sub-Saharan Africa and beyond.

🔹 Conclusion

Given his exceptional research output, global impact, and dedication to scientific advancements, Dr. Blaise Dondji is a highly suitable candidate for the Best Researcher Award. His pioneering research, influential mentorship, and ability to secure significant funding position him as a distinguished scientist whose contributions have greatly advanced the field of immunology and infectious disease research.

Publication

Publication: “Distribution and ecological aspects of sand fly species from Kousseri, an endemic focus of visceral leishmaniasis in Northern Cameroon”

Authors: Tebo-Nzesseu Thierry Rostand, Tateng Ngouateu Aime, Ngouateu Omer Bébé Kenfack, Vincent Khan Payne, Blaise Dondji

Journal: Frontiers in Tropical Diseases

Year: 2024

Citations: 0

Publication: “Ecological site distribution of sand fly species of Mokolo, an endemic focus of cutaneous leishmaniasis in northern Cameroon”

Authors: Aime Tateng Ngouateu, Omer Bébé Ngouateu Kenfack, Vincent Khan Payne, Andreas Krüger, Blaise Dondji

Journal: Acta Tropica

Year: 2023

Citations: 3

Publication: “Assessment of the anthelmintic activity and toxicity of metabolites of Dalea pogonathera (Fabaceae)”

Authors: Victoria McPherson, Haley Wolhart, Lindsay Engels, Gil N. Belofsky, Blaise Dondji

Journal: Phytochemistry Letters

Year: 2022

Citations: 1